TrialCancer science2012

SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology Group.

Satoshi Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.